Michele Nichelatti

Author PubWeight™ 47.16‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Endovascular treatment for acute ischemic stroke. N Engl J Med 2013 8.45
2 PIK3CA mutations in colorectal cancer are associated with clinical resistance to EGFR-targeted monoclonal antibodies. Cancer Res 2009 4.82
3 Epidermal growth factor receptor gene copy number and clinical outcome of metastatic colorectal cancer treated with panitumumab. J Clin Oncol 2007 2.19
4 Multi-determinants analysis of molecular alterations for predicting clinical benefit to EGFR-targeted monoclonal antibodies in colorectal cancer. PLoS One 2009 2.18
5 Asymptomatic lipomas of the medullary conus: surgical treatment versus conservative management. J Neurosurg Pediatr 2014 2.16
6 Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study. Blood 2005 1.87
7 Pru p 3-sensitised Italian peach-allergic patients are less likely to develop severe symptoms when also presenting IgE antibodies to Pru p 1 and Pru p 4. Int Arch Allergy Immunol 2011 1.48
8 Alemtuzumab as consolidation after a response to fludarabine is effective in purging residual disease in patients with chronic lymphocytic leukemia. J Clin Oncol 2006 1.30
9 SYNTHESIS expansion: design of a nonprofit, pragmatic, randomized, controlled trial on the best fast-track endovascular treatment vs. standard intravenous alteplase for acute ischemic stroke. Int J Stroke 2011 1.12
10 Outcome of hyperleukocytic adult acute myeloid leukaemia: a single-center retrospective study and review of literature. Leuk Res 2008 1.01
11 Fermented wheat germ extract (Avemar) in the treatment of cancer and autoimmune diseases. Ann N Y Acad Sci 2005 0.93
12 Down-regulation of microRNAs 222/221 in acute myelogenous leukemia with deranged core-binding factor subunits. Neoplasia 2010 0.93
13 Promoter CpG island hypermethylation of the DNA repair enzyme MGMT predicts clinical response to dacarbazine in a phase II study for metastatic colorectal cancer. Clin Cancer Res 2013 0.91
14 Utility of percutaneous lung biopsy for diagnosing filamentous fungal infections in hematologic malignancies. Haematologica 2003 0.90
15 ZAP-70, IgVh, and cytogenetics for assessing prognosis in chronic lymphocytic leukemia. Cancer Biomark 2010 0.85
16 Serum tryptase: a new biomarker in patients with acute coronary syndrome? Int Arch Allergy Immunol 2014 0.84
17 Fludarabine plus cyclophosphamide and rituximab in Waldenstrom macroglobulinemia: an effective but myelosuppressive regimen to be offered to patients with advanced disease. Cancer 2011 0.84
18 Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: definition and management of the risk related to zoledronic acid. Clin Lymphoma Myeloma 2008 0.82
19 Old and new prognostic factors in acute myeloid leukemia with deranged core-binding factor beta. Am J Hematol 2013 0.82
20 Invasive fungal infections in lymphoproliferative disorders: a monocentric retrospective experience. Leuk Lymphoma 2014 0.81
21 Twice daily fludarabine/Ara-C associated to idarubicin, G-CSF and ATRA is an effective salvage regimen in non-promyelocytic acute myeloid leukemia. Leuk Res 2009 0.81
22 Plasma HIV load and proviral DNA decreases after two standard antiretroviral regimens in HIV-positive patients naïve to antiretrovirals. Curr HIV Res 2008 0.81
23 Factors predicting transformation of asymptomatic IgM monoclonal gammopathy. Clin Lymphoma Myeloma Leuk 2011 0.81
24 Survival in patients treated by long-term dialysis compared with the general population. Am J Kidney Dis 2012 0.81
25 Prospective monocentric study of non-tunnelled central venous catheter-related complications in hematological patients. Leuk Lymphoma 2008 0.81
26 Magnetic resonance imaging as an early indicator of clinical outcome in patients with metastatic colorectal carcinoma treated with cetuximab or panitumumab. Clin Colorectal Cancer 2012 0.80
27 High-dose idarubicin in combination with Ara-C in patients with relapsed or refractory acute lymphoblastic leukemia: a pharmacokinetic and clinical study. Cancer Chemother Pharmacol 2007 0.80
28 Wake-up stroke and TIA due to paradoxical embolism during long obstructive sleep apnoeas: a cross-sectional study. Thorax 2012 0.80
29 Anti-rPru p 3 IgE levels are inversely related to the age at onset of peach-induced severe symptoms reported by peach-allergic adults. Int Arch Allergy Immunol 2013 0.79
30 Fennel allergy is a lipid-transfer protein (LTP)-related food hypersensitivity associated with peach allergy. J Agric Food Chem 2013 0.79
31 Hematological improvement during iron-chelation therapy in myelodysplastic syndromes: the experience of the "Rete Ematologica Lombarda". Leuk Res 2013 0.79
32 Rice allergy demonstrated by double-blind placebo-controlled food challenge in peach-allergic patients is related to lipid transfer protein reactivity. Int Arch Allergy Immunol 2013 0.78
33 Automated APTT cycle for the rapid identification of plasma prekallikrein deficiency. Thromb Res 2010 0.77
34 Fludarabine, cyclophosphamide, and rituximab in salvage therapy of Waldenström's macroglobulinemia. Clin Lymphoma Myeloma Leuk 2013 0.77
35 Gene expression profiling identifies ARSD as a new marker of disease progression and the sphingolipid metabolism as a potential novel metabolism in chronic lymphocytic leukemia. Cancer Biomark 2012 0.77
36 Total serum tryptase: a predictive marker for KIT mutation in acute myeloid leukemia. Leuk Res 2009 0.76
37 Recovering incidence from repeated measures of prevalence: the case of urinary tract infections. J Clin Monit Comput 2010 0.75
38 [Assessment of treatment quality by hierarchical models in the Italian dialysis and transplantation registry]. G Ital Nefrol 2011 0.75
39 Should a positive direct antiglobulin test be considered a prognostic predictor in chronic lymphocytic leukemia? Clin Lymphoma Myeloma Leuk 2013 0.75
40 Anti-Amoxicillin Immunoglobulin E, Histamine-2 Receptor Antagonist Therapy and Mast Cell Activation Syndrome Are Risk Factors for Amoxicillin Anaphylaxis. Int Arch Allergy Immunol 2015 0.75
41 Verifying Hellström-Lindberg score as predictive tool for response to erythropoietin therapy according to the "International Working Group" criteria, in anemic patients affected by myelodysplastic syndrome: a monocentric experience. Int J Hematol 2013 0.75
42 [Changes in the uremic population overtime: data from the Italian Registry of Dialysis and Transplantation (RIDT)]. G Ital Nefrol 2012 0.75